At a time when insurers are backing away from coverage for weight loss medications, President Trump has offered a lifeline ...

Recent Gallup data shows a decline in U.S. obesity rates, likely linked to widespread use of GLP-1 drugs like Ozempic and Wegovy.

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

A Thursday Oval Office event, where President Donald Trump announced price reductions for weight-loss drugs, was interrupted by a health emergency.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and Novo Nordisk, special vouchers that will speed up the review of their medicines, ...